| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Administration of the carcinogen ethylene dibromide (EDB) to rats resulted in the urinary excretion of S-[2-N7-guanyl)ethyl]-N-acetylcysteine, which is derived from the nucleic acid adduct S-[2-(N7-guanyl)ethyl]glutathione. This mercapturic acid was isolated from urine by reversed-phase and propylamino high-performance liquid chromatography and was quantitated by measurement of fluorescence intensity. The urinary mercapturic acid was identified as S-[2-(N7-guanyl)ethyl]-N-acetylcysteine on the basis of cochromatography and UV, fluorescence, 1H nuclear magnetic resonance, and fast atom bombardment mass spectra, all of which were identical with the authentic synthesized material. The excretion of mercapturic acid into urine of rats given injections of various doses of EDB occurred in a dose-dependent, linear manner over the range of 0.537 mg EDB/kg body weight. A good correlation was found between the excretion of mercapturic acid and the (in vivo) formation of DNA adducts in liver and kidney DNA. The higher level of urinary mercapturic acid compared to the level of hepatic DNA adduct indicates that extra-hepatic DNA adducts and RNA adducts may contribute to the mercapturic acid production. The measurement of the mercapturic acid may provide a means of noninvasive estimation of DNA adducts derived from EDB exposure.
1 Supported in part by USPHS Grants CA 44353, ES 00267, and ES 01590.
2 Burroughs Wellcome Scholar in Toxicology (19831988). To whom requests for reprints should be addressed.
Received 2/ 3/89. Revised 8/ 1/89. Accepted 8/ 7/89.
This article has been cited by other articles:
![]() |
M. B. Otteneder, C. G. Knutson, J. S. Daniels, M. Hashim, B. C. Crews, R. P. Remmel, H. Wang, C. Rizzo, and L. J. Marnett In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG PNAS, April 25, 2006; 103(17): 6665 - 6669. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Wormhoudt, A. M. Hissink, J. N. M. Commandeur, P. J. van Bladeren, and N. P. E. Vermeulen Disposition of 1,2-[14C]Dibromoethane in Male Wistar Rats Drug Metab. Dispos., May 1, 1998; 26(5): 437 - 447. [Abstract] [Full Text] |
||||
![]() |
L. W. Wormhoudt, J. N. M. Commandeur, J. H. T. M. Ploemen, R. S. Abdoelgafoer, A. Makansi, P. J. van Bladeren, and N. P. E. Vermeulen Urinary Thiodiacetic Acid. A Selective Biomarker for the Cytochrome P450-Catalyzed Oxidation of 1,2-Dibromoethane in the Rat Drug Metab. Dispos., April 1, 1997; 25(4): 508 - 515. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |